Clinical trial · Interventional
Full-spectrum Endoscopy in Colorectal Cancer Screening
Impact of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Controlled Trial
NCT02812550CI-TRIAL-00022728completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare the adenoma detection rates of full-spectrum endoscopy versus standard forward-viewing colonoscopy in colorectal cancer screening programme.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| colonoscopy procedure | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- full-spectrum colonoscopy
- description
- Colonoscopy is performed with a full-spectrum colonoscopy (330º angle of view)
- interventionNames
- Procedure: colonoscopy procedure
- type
- OTHER
- label
- standar forward-viewing colonoscopy
- description
- Colonoscopy is performed with standar forward-viewing colonoscopy (170º angle of view)
- interventionNames
- Procedure: colonoscopy procedure
Primary outcomes (1)
- measure
- adenoma detection rate in the two different colonoscopies
- timeFrame
- one week
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * patient referred for colorectal cancer screening with positive fecal inmunological test. * Age between 50 and 69 years Exclusion Criteria: * history of colonic resection, * high risk for colorectal cancer like family history of colorectal cancer o polyposis syndrome, * inflammatory bowel disease, * patients with lower gastrointestinal bleeding symptoms, * acute diverticulitis, * colonic strictures, * poor bowel preparation (Boston scale less than 5 points)
References
Publications (1)
- DERIVEDNunez-Rodriguez H, Diez-Redondo P, Perez-Miranda M, Gonzalez Sagrado M, Conde R, De la Serna C. Role of Full-spectrum Endoscopy in Colorectal Cancer Screening: Randomized Trial. J Clin Gastroenterol. 2019 Mar;53(3):191-196. doi: 10.1097/MCG.0000000000000975. PMID 29283904